Brief: Hutchmed (China) Says Weiguo Su Takes Leave As CEO Due To Health Reasons
Aug 25 (Reuters) - HUTCHMED (China) Ltd 0013.HK: WEIGUO SU TAKES LEAVE AS CEO DUE TO HEALTH REASONS JOHNNY CHENG APPOINTED ACTING CEO OF HUTCHMED Further company coverage: 0013.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on HUTCHMED (China)
See all newsKras: EGFR-Antibody licensing deal with GSK closes
Brief: Hutchmed (China) Closes Exclusive Development And License Agreement With GSK Unit
Factbox: Major drugmakers turn to China for licensing deals
Factbox: Major drugmakers turn to China for licensing deals
Factbox: Major drugmakers turn to China for licensing deals